Criteria – Three-Step Test In order for the disputed domain names to be either cancelled or transferred, a panellist/panel must find that the following three conditions are met: The domain name registered by the domain name registrant is identical or confusingly...
The EBA have supplied a short answer in Decision G 1/15: No it cannot. This appears to be a sensible conclusion and the decision provides a comprehensive analysis of the case law leading up to the decision, the legal framework supporting priority, the effects of...
Background Arrow Declarations are declarations regarding the validity of subject-matter (rather than specific patents) and provide accused infringers of legal certainty that their proposed activities will not fall within the scope of any valid patent that may be...
The statement from the Unified Patent Court (UPC) Preparatory Committee indicating that they are currently working under the assumption that the UPC will become operational in December 2017 follows the shock announcement in November 2016 that the UK will proceed with...
Introduction The Cancer Immunotherapy Pilot Program, also known as “Patents 4 Patients”, makes certain US patent applications relating to cancer immunotherapy eligible for special status and examination with the goal of completing prosecution within 12...
Background Article 6(2) of the EU Biotech Directive excludes uses of human embryos for industrial or commercial purposes from patentability[1]. This exclusion does not affect inventions for therapeutic or diagnostic purposes which are applied to the human embryo and...
Recent Comments